How Global Medtech Trends Are Redefining South Asia's Healthcare Economy

Medtech Trends 2026: Strategic Implications for South Asia's Medical Technology Industry

Executive Summary

The global medical technology (medtech) sector is at an inflection point, with structural forces reshaping pricing, care delivery, supply chains, and technological competition. Clarivate's Medtech Trends to Watch 2026 identifies five pivotal trends: the expanding impact of China's volume-based procurement (VBP), the shift to outpatient and ambulatory surgical centers (ASCs), persistent supply chain pressures, the rise of GLP-1 receptor agonists, and the emergence of platform-based competition driven by enabling technologies. For South Asia—a region with rapidly growing healthcare demand, expanding manufacturing capabilities, and increasing integration into global value chains—these trends carry significant strategic weight. This analysis explores each trend's regional relevance, investment implications, and long-term economic consequences for South Asian nations.

Introduction

South Asia stands at the intersection of global healthcare transformation and regional economic ambition. With a combined population exceeding 1.8 billion, rising middle classes, and improving healthcare infrastructure, the region is becoming an increasingly important market for medical technology. Simultaneously, countries like India, Bangladesh, and Sri Lanka are seeking to strengthen domestic production and export capacity in the medical device sector. Understanding global medtech trends is therefore not merely an exercise in market intelligence; it is essential for aligning South Asia's industrial policies, investment attraction strategies, and healthcare delivery reforms with the realities of a changing global industry.

Main Analysis

#### 1. Mainland China's VBP Expansion: A Catalyst for South Asia's Manufacturing Ambitions

China's evolving volume-based procurement (VBP) program is compressing device prices and reshaping market access dynamics globally. As multinationals recalibrate their China strategies, they are diversifying production and exploring lower-cost manufacturing bases. South Asia offers a compelling alternative: India's medical device sector is growing at 13–15% annually, supported by government initiatives like the Production-Linked Incentive (PLI) scheme. Bangladesh and Sri Lanka are also investing in high-value manufacturing. For South Asian policymakers, VBP signals the need to accelerate regulatory harmonization, improve infrastructure, and incentivize technology transfer to attract companies seeking resilient, cost-effective production hubs.

#### 2. Outpatient and ASC Settings: Redefining Healthcare Delivery in South Asia

The global migration of procedures to outpatient settings is mirrored in South Asia, where private hospital chains are expanding day-care surgery centers and diagnostic facilities. This shift creates demand for compact, user-friendly devices suited for ASCs, as well as for digital health solutions that enable remote monitoring. For regional device manufacturers, this represents an opportunity to innovate in product design and supply chain logistics. Investors should note that healthcare providers with strong outpatient networks are likely to experience increased procedure volumes, driving revenue growth and creating attractive private equity and venture capital opportunities.

#### 3. Supply Chain Pressures: South Asia as a Resilient Manufacturing Destination

Global tariff disputes, geopolitical tensions, and material cost volatility are prompting medtech companies to diversify supply chains away from concentration in a single country. South Asia is well-positioned to benefit from this "China+1" strategy. India, in particular, has made strides in electronics and precision manufacturing, and its large engineering workforce is an asset. However, gaps remain in component ecosystems, quality certifications, and logistics infrastructure. Governments across the region should treat supply chain resilience as a strategic priority, investing in industrial parks, trade facilitation, and skill development to capture a larger share of global medtech production.

#### 4. GLP-1 Therapies: Implications for South Asia's Metabolic Disease Burden

South Asia faces one of the world's highest burdens of diabetes and obesity. The rapid adoption of GLP-1 receptor agonists—drugs that manage weight and blood sugar—has the potential to transform treatment pathways and reduce the need for certain surgical interventions. This shift will have ripple effects across the medtech ecosystem: demand for glucose monitoring devices and cardiovascular diagnostics may rise, while utilization of bariatric surgery could see volume pressure. Domestic pharmaceutical companies in India are already ramping up GLP-1 production, which could improve access and lower costs. For regional health systems, integrating GLP-1 therapies into care pathways requires investments in diagnostic infrastructure and clinical training.

#### 5. Platform-Based Competition: Building Digital and Surgical Ecosystems

The convergence of robotics, imaging, navigation, and digital workflows is moving medtech competition from isolated devices to integrated platforms. In South Asia, this trend is visible in the expansion of robotic surgery programs in major urban hospitals, as well as the emergence of local health-tech startups offering AI-powered diagnostic tools. Platform-based competition favors companies that can provide end-to-end solutions, fostering partnerships between global technology firms and regional healthcare providers. To fully participate, South Asian firms need to invest in R&D, data interoperability standards, and skills development—areas where regional cooperation can accelerate progress.

Regional Impact

The five medtech trends collectively have the potential to reshape South Asia's economic landscape:

• Economic Growth and Industrial Development: Local manufacturing of medical devices and associated technologies can boost GDP, create high-skilled jobs, and reduce import dependence.
• Trade Integration: As supply chains realign, South Asia can increase its share of global medtech exports, strengthening trade ties within the region and beyond.
• Foreign Investment: Multinationals seeking resilient production hubs may relocate or expand operations in India, Bangladesh, and Sri Lanka, bringing capital and technology.
• Technology Adoption: The shift toward platform-based and digital health solutions offers an opportunity to leapfrog legacy systems, improving healthcare access in underserved areas.
• Healthcare Transformation: Outpatient care models and GLP-1 therapies could reduce healthcare costs and improve patient outcomes, but require infrastructure and policy adjustments.

Strategic Insights

• Business Diversification: South Asian manufacturers should diversify their product lines to include ASC-compatible and digitally integrated devices, aligning with global demand.
• Policy Alignment: Governments must streamline regulatory processes, adopt international quality standards, and provide incentives for R&D to attract investment in high-value segments.
• Investment Priorities: Infrastructure—especially digital infrastructure and logistics—remains a bottleneck; public-private partnerships can accelerate development.
• Regional Cooperation: Cross-border collaboration on manufacturing standards, data sharing, and talent mobility can enhance the region's collective competitiveness.
• Partnerships: South Asian firms should seek alliances with global tech companies to access platform technologies and integrate into international value chains.

Future Outlook

Over the next 3–5 years, South Asia's medtech sector is poised for significant growth. The region's large market, cost-competitive labor, and improving business environment make it an increasingly attractive destination for global companies seeking alternative production bases and new growth markets.

• Digital Health Expansion: Telemedicine, AI diagnostics, and remote monitoring will become mainstream, supported by expanding internet penetration and smartphone adoption.
• Manufacturing Scale-Up: India's PLI scheme and similar policies will catalyze local production of high-value devices, reducing imports and boosting exports.
• Regional Trade Integration: Agreements like BIMSTEC and SAFTA may evolve to include medical device mutual recognition, facilitating intra-regional trade.
• Investment Flows: Private equity and venture capital investment in healthcare technology will likely rise, with a focus on platform-based solutions and outpatient care models.
• Skills Development: Educational institutions will need to train workers in advanced manufacturing and digital health to meet industry demands.

Conclusion

The global medtech trends outlined by Clarivate are not isolated phenomena; they are intertwined with South Asia's economic transformation. By recognizing these shifts and responding strategically, South Asian nations can enhance their healthcare systems, attract foreign investment, and position themselves as formidable players in the global medical technology landscape. The challenge lies in executing coordinated policies that foster innovation, infrastructure, and regional cooperation—essential ingredients for turning disruption into opportunity.

Key Takeaways

• China's VBP expansion creates a window for South Asia to attract medtech manufacturing relocations.
• Outpatient and ASC trends align with the region's expanding private healthcare networks.
• Supply chain resilience is a strategic opportunity for South Asian producers.
• GLP-1 therapies will reshape metabolic disease care, affecting device demand in South Asia.
• Platform-based competition demands investment in robotics, AI, and digital infrastructure.
• Regional cooperation and policy alignment are critical to realizing these opportunities.

Sources

• Clarivate. "5 medtech trends to watch in 2026." https://clarivate.com/life-sciences-healthcare/blog/5-medtech-trends-to-watch-in-2026

Article originally published on SouthAsiaPulse.com, an international publication focused on South Asia's economic and business transformation.